title: Soluble HLA class I serum concentrations increase with transplant-related complications after liver transplantation.
authors.forename: H
authors.initials: H
authors.lastname: Tilg
authors.forename: U
authors.initials: U
authors.lastname: Westhoff
authors.forename: W
authors.initials: W
authors.lastname: Vogel
authors.forename: W E
authors.initials: WE
authors.lastname: Aulitzky
authors.forename: M
authors.initials: M
authors.lastname: Herold
authors.forename: R
authors.initials: R
authors.lastname: Margreiter
authors.forename: C
authors.initials: C
authors.lastname: Huber
authors.forename: H
authors.initials: H
authors.lastname: Grosse-Wilde
mesh_terms: D000328:Adult; D001424:Bacterial Infections / Q000209:etiology / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000209:etiology / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006084:Graft Rejection; D006680:HLA Antigens / Q000032:analysis*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016031:Liver Transplantation / Q000009:adverse effects* / Q000276:immunology*; D008297:Male; D001613:beta 2-Microglobulin / Q000032:analysis
chemical_list: D006680:HLA Antigens; D007166:Immunosuppressive Agents; D001613:beta 2-Microglobulin